Ketojoice Tablet contains Alpha Ketoanalogue (NA), a specialized supplement used primarily in the management of chronic kidney disease (CKD). Alpha Ketoanalogues are nitrogen-free analogues of essential amino acids that play a crucial role in reducing nitrogenous waste accumulation in patients with compromised renal function. By providing the body with ketoanalogues, Ketojoice facilitates the synthesis of essential amino acids without increasing the nitrogen load, thereby helping to minimize uremic toxicity and delay the progression of renal impairment. This therapeutic approach is often employed alongside a controlled low-protein diet to optimize nutritional status while reducing the burden on the kidneys. Ketojoice Tablet is indicated for patients with moderate to severe CKD who require dietary protein restriction but need to maintain adequate nutrition. The medication should be used under medical supervision, with dosage tailored according to the patient’s renal function and nutritional needs. It is contraindicated in individuals with hypersensitivity to any component of the formulation. Common side effects are generally mild but may include gastrointestinal discomfort or allergic reactions. Regular monitoring of renal parameters and nutritional status is essential during therapy to ensure efficacy and safety. Ketojoice Tablet represents an important adjunct in the conservative management of CKD, aiming to improve patient outcomes and quality of life.